Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A

Francois H T Duong1, Magdalena Filipowicz, Marco Tripodi

  • 1Department of Research, University Hospital Basel, Basel, Switzerland.

Gastroenterology
|December 31, 2003
PubMed
Abstract

Insights

Hepatitis C virus (HCV) impairs interferon-alpha signaling in chronic hepatitis C patients by upregulating PP2Ac, leading to STAT1 hypomethylation and reduced gene activation. This explains a key viral immune evasion mechanism.

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Hepatitis C virus (HCV) evades host defenses to establish chronic infection.
  • HCV proteins inhibit interferon-alpha-induced Jak-STAT signaling in cell cultures and transgenic mice.
  • The inhibition of interferon-alpha signaling in chronic hepatitis C patients and its mechanisms remain unclear.

Purpose of the Study:

  • To investigate interferon-alpha signaling in liver biopsies from chronic hepatitis C patients.
  • To elucidate the molecular mechanisms by which HCV interferes with Jak-STAT signaling.

Main Methods:

  • Analysis of interferon-alpha-induced signaling in liver biopsies from chronic hepatitis C patients and controls.
  • Investigation of molecular mechanisms in cultured cells, HCV transgenic mice, and patient liver biopsies.
  • Assessment of STAT1 phosphorylation, methylation, and association with PIAS1.
  • Quantification of Protein Phosphatase 2A (PP2Ac) expression levels.

Main Results:

  • STAT1 DNA binding was impaired in chronic hepatitis C patients.
  • STAT1 phosphorylation was intact, but arginine 31 methylation was reduced, leading to hypomethylation.
  • Hypomethylated STAT1 showed increased association with PIAS1, an inhibitor of STAT DNA binding.
  • Increased PP2Ac expression was observed in HCV transgenic mice and chronic hepatitis C patients.
  • Overexpression of PP2Ac in cells mimicked the effects on STAT1 and interferon-alpha signaling.

Conclusions:

  • HCV interferes with interferon-alpha signaling through PP2Ac upregulation and STAT1 hypomethylation.
  • This leads to increased STAT1-PIAS1 association, inhibiting STAT1 DNA binding.
  • Reduced transcriptional activation of interferon-alpha-stimulated genes is a consequence of this interference.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
73
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
87
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49